Correlation Between Cannabics Pharmaceuticals and Pmv Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannabics Pharmaceuticals and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabics Pharmaceuticals and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannabics Pharmaceuticals and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Cannabics Pharmaceuticals and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabics Pharmaceuticals with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabics Pharmaceuticals and Pmv Pharmaceuticals.

Diversification Opportunities for Cannabics Pharmaceuticals and Pmv Pharmaceuticals

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Cannabics and Pmv is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Cannabics Pharmaceuticals and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Cannabics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabics Pharmaceuticals are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Cannabics Pharmaceuticals i.e., Cannabics Pharmaceuticals and Pmv Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cannabics Pharmaceuticals and Pmv Pharmaceuticals

Given the investment horizon of 90 days Cannabics Pharmaceuticals is expected to generate 3.06 times more return on investment than Pmv Pharmaceuticals. However, Cannabics Pharmaceuticals is 3.06 times more volatile than Pmv Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  400.00  in Cannabics Pharmaceuticals on September 4, 2024 and sell it today you would lose (399.07) from holding Cannabics Pharmaceuticals or give up 99.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cannabics Pharmaceuticals  vs.  Pmv Pharmaceuticals

 Performance 
       Timeline  
Cannabics Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabics Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Cannabics Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Pmv Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Pmv Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Cannabics Pharmaceuticals and Pmv Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannabics Pharmaceuticals and Pmv Pharmaceuticals

The main advantage of trading using opposite Cannabics Pharmaceuticals and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabics Pharmaceuticals position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.
The idea behind Cannabics Pharmaceuticals and Pmv Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities